| GXG | Name: | 4-(2,6-difluorophenyl)-2,4-dioxobutanoic acid | Formula: | C10 H6 F2 O4 | SMILES: | c1(cccc(c1C(CC(C(O)=O)=O)=O)F)F | InChi: | InChI=1S/C10H6F2O4/c11-5-2-1-3-6(12)9(5)7(13)4-8(14)10(15)16/h1-3H,4H2,(H,15,16) | Definition date: | 2018-06-01 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | 4-(2,6-difluorophenyl)-2,4-dioxobutanoic acid |
|
| GXM | Name: | (2Z)-2-hydroxy-4-(2-nitrophenyl)-4-oxobut-2-enoic acid | Formula: | C10 H7 N O6 | SMILES: | c1(ccccc1C([C@H]=C(C(O)=O)O)=O)[N+]([O-])=O | InChi: | InChI=1S/C10H7NO6/c12-8(5-9(13)10(14)15)6-3-1-2-4-7(6)11(16)17/h1-5,13H,(H,14,15)/b9-5- | Definition date: | 2018-06-04 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | (2Z)-2-hydroxy-4-(2-nitrophenyl)-4-oxobut-2-enoic acid |
|
| GZ4 | Name: | 7,8-dimethyl-2,4-dioxo-10-(3-phenylpropyl)-1,2,3,4-tetrahydrobenzo[g]pteridin-10-ium | Formula: | C21 H21 N4 O2 | SMILES: | c13C(NC(=O)Nc1[n+](c2cc(C)c(cc2n3)C)CCCc4ccccc4)=O | InChi: | InChI=1S/C21H20N4O2/c1-13-11-16-17(12-14(13)2)25(10-6-9-15-7-4-3-5-8-15)19-18(22-16)20(26)24-21(27)23-19/h3-5,7-8,11-12H,6,9-10H2,1-2H3,(H,24,26,27)/p+1 | Definition date: | 2018-06-06 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | 7,8-dimethyl-2,4-dioxo-10-(3-phenylpropyl)-1,2,3,4-tetrahydrobenzo[g]pteridin-10-ium |
|
| GZ7 | Name: | 10-(6-carboxyhexyl)-8-(cyclopentylamino)-2,4-dihydroxy-7-methylbenzo[g]pteridin-10-ium | Formula: | C23 H30 N5 O4 | SMILES: | c1(c2c(nc(n1)O)[n+](CCCCCCC(=O)O)c3cc(c(cc3n2)C)NC4CCCC4)O | InChi: | InChI=1S/C23H29N5O4/c1-14-12-17-18(13-16(14)24-15-8-5-6-9-15)28(11-7-3-2-4-10-19(29)30)21-20(25-17)22(31)27-23(32)26-21/h12-13,15H,2-11H2,1H3,(H3,24,26,27,29,30,31,32)/p+1 | Definition date: | 2018-06-06 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | 10-(6-carboxyhexyl)-8-(cyclopentylamino)-2,4-dihydroxy-7-methylbenzo[g]pteridin-10-ium |
|
| GZG | Name: | 4-{benzyl[2-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)ethyl]amino}butanoic acid | Formula: | C25 H27 N5 O4 | SMILES: | C(N(Cc1ccccc1)CCCC(=O)O)CN3c4c(N=C2C(NC(=O)N=C23)=O)cc(c(c4)C)C | InChi: | InChI=1S/C25H27N5O4/c1-16-13-19-20(14-17(16)2)30(23-22(26-19)24(33)28-25(34)27-23)12-11-29(10-6-9-21(31)32)15-18-7-4-3-5-8-18/h3-5,7-8,13-14H,6,9-12,15H2,1-2H3,(H,31,32)(H,28,33,34) | Definition date: | 2018-06-06 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | 4-{benzyl[2-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)ethyl]amino}butanoic acid |
|
| GZV | Name: | (2Z)-4-(2,6-difluoro-3-methylphenyl)-2-hydroxy-4-oxobut-2-enoic acid | Formula: | C11 H8 F2 O4 | SMILES: | C(/C(c1c(ccc(C)c1F)F)=O)=C(C(O)=O)O | InChi: | InChI=1S/C11H8F2O4/c1-5-2-3-6(12)9(10(5)13)7(14)4-8(15)11(16)17/h2-4,15H,1H3,(H,16,17)/b8-4- | Definition date: | 2018-06-08 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | (2Z)-4-(2,6-difluoro-3-methylphenyl)-2-hydroxy-4-oxobut-2-enoic acid |
|
| 54B | Name: | 1-ethyl-3-[5-[2-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]-5-(2-oxidanylidene-3H-1,3,4-oxadiazol-5-yl)pyridin-3-yl]-4-[4-(trifluoromethyl)-1,3-thiazol-2-yl]pyridin-2-yl]urea | Formula: | C26 H26 F3 N9 O3 S | SMILES: | CCNC(=O)Nc1cc(c2scc(n2)C(F)(F)F)c(cn1)c3cc(cnc3N4[CH]5CC[CH]4CN(C)C5)C6=NNC(=O)O6 | InChi: | InChI=1S/C26H26F3N9O3S/c1-3-30-24(39)34-20-7-17(23-33-19(12-42-23)26(27,28)29)18(9-31-20)16-6-13(22-35-36-25(40)41-22)8-32-21(16)38-14-4-5-15(38)11-37(2)10-14/h6-9,12,14-15H,3-5,10-11H2,1-2H3,(H,36,40)(H2,30,31,34,39)/t14-,15+ | Definition date: | 2015-07-23 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | 1-ethyl-3-[5-[2-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]-5-(2-oxidanylidene-3H-1,3,4-oxadiazol-5-yl)pyridin-3-yl]-4-[4-(trifluoromethyl)-1,3-thiazol-2-yl]pyridin-2-yl]urea |
|
| HRA | Name: | 1,5-anhydro-2-{[5-(2-chloro-4-phenoxybenzene-1-carbonyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-2,3,4-trideoxy-D-erythro-hexitol | Formula: | C25 H23 Cl N4 O4 | SMILES: | C1CC(CO)OCC1Nc5c4c(C(c3ccc(Oc2ccccc2)cc3Cl)=O)cnc4ncn5 | InChi: | InChI=1S/C25H23ClN4O4/c26-21-10-17(34-16-4-2-1-3-5-16)8-9-19(21)23(32)20-11-27-24-22(20)25(29-14-28-24)30-15-6-7-18(12-31)33-13-15/h1-5,8-11,14-15,18,31H,6-7,12-13H2,(H2,27,28,29,30)/t15-,18+/m1/s1 | Definition date: | 2018-07-18 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | 1,5-anhydro-2-{[5-(2-chloro-4-phenoxybenzene-1-carbonyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-2,3,4-trideoxy-D-erythro-hexitol |
|
| 9UO | Name: | 6-(6-chloropyridin-2-yl)-N2,N4-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine | Formula: | C14 H13 Cl F6 N6 | SMILES: | c1(nc(NC(C)C(F)(F)F)nc(n1)NC(C)C(F)(F)F)c2nc(Cl)ccc2 | InChi: | InChI=1S/C14H13ClF6N6/c1-6(13(16,17)18)22-11-25-10(8-4-3-5-9(15)24-8)26-12(27-11)23-7(2)14(19,20)21/h3-7H,1-2H3,(H2,22,23,25,26,27)/t6-,7-/m1/s1 | Definition date: | 2018-08-06 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | 6-(6-chloropyridin-2-yl)-N~2~,N~4~-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine |
|
| AO8 | Name: | [2-[[2-(isoquinolin-5-ylsulfonylamino)ethylamino]methyl]phenyl]boronic acid | Formula: | C18 H20 B N3 O4 S | SMILES: | OB(O)c1ccccc1CNCCN[S](=O)(=O)c2cccc3cnccc23 | InChi: | InChI=1S/C18H20BN3O4S/c23-19(24)17-6-2-1-4-15(17)13-21-10-11-22-27(25,26)18-7-3-5-14-12-20-9-8-16(14)18/h1-9,12,21-24H,10-11,13H2 | Definition date: | 2017-08-22 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | [2-[[2-(isoquinolin-5-ylsulfonylamino)ethylamino]methyl]phenyl]boronic acid |
|
| AT8 | Name: | 2-[5,6-bis(chloranyl)-1~{H}-benzimidazol-2-yl]-~{N}-[[3-chloranyl-4-(2-ethylphenyl)phenyl]methyl]ethanamine | Formula: | C24 H22 Cl3 N3 | SMILES: | CCc1ccccc1c2ccc(CNCCc3[nH]c4cc(Cl)c(Cl)cc4n3)cc2Cl | InChi: | InChI=1S/C24H22Cl3N3/c1-2-16-5-3-4-6-17(16)18-8-7-15(11-19(18)25)14-28-10-9-24-29-22-12-20(26)21(27)13-23(22)30-24/h3-8,11-13,28H,2,9-10,14H2,1H3,(H,29,30) | Definition date: | 2017-08-22 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | 2-[5,6-bis(chloranyl)-1~{H}-benzimidazol-2-yl]-~{N}-[[3-chloranyl-4-(2-ethylphenyl)phenyl]methyl]ethanamine |
|
| AU2 | Name: | 2-(1~{H}-benzimidazol-2-yl)ethyl-[[3,5-bis(chloranyl)-4-phenyl-phenyl]methyl]azanium | Formula: | C22 H20 Cl2 N3 | SMILES: | Clc1cc(C[NH2+]CCc2[nH]c3ccccc3n2)cc(Cl)c1c4ccccc4 | InChi: | InChI=1S/C22H19Cl2N3/c23-17-12-15(13-18(24)22(17)16-6-2-1-3-7-16)14-25-11-10-21-26-19-8-4-5-9-20(19)27-21/h1-9,12-13,25H,10-11,14H2,(H,26,27)/p+1 | Definition date: | 2017-08-22 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | 2-(1~{H}-benzimidazol-2-yl)ethyl-[[3,5-bis(chloranyl)-4-phenyl-phenyl]methyl]azanium |
|
| 8ZR | Name: | ~{N},~{N},12-trimethyl-3$l^{3}-thia-1$l^{4},5,6$l^{4}-triaza-2$l^{3}-cupratricyclo[6.4.0.0^{2,6}]dodeca-1(8),3,6,9,11-pentaen-4-amine | Formula: | C10 H14 Cu N4 S | SMILES: | [Cu].CN(C)C(=S)NN=Cc1cccc(C)n1 | InChi: | InChI=1S/C10H14N4S.Cu/c1-8-5-4-6-9(12-8)7-11-13-10(15)14(2)3 | Definition date: | 2017-11-14 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | ~{N},~{N},12-trimethyl-3$l^{3}-thia-1$l^{4},5,6$l^{4}-triaza-2$l^{3}-cupratricyclo[6.4.0.0^{2,6}]dodeca-1(8),3,6,9,11-pentaen-4-amine |
|
| 93C | Name: | N-[4-(2-oxopyrrolidin-1-yl)phenyl]-2-(pyridin-2-yl)pyrimidine-5-carboxamide | Formula: | C20 H17 N5 O2 | SMILES: | c1ccnc(c1)c4ncc(C(=O)Nc3ccc(N2C(=O)CCC2)cc3)cn4 | InChi: | InChI=1S/C20H17N5O2/c26-18-5-3-11-25(18)16-8-6-15(7-9-16)24-20(27)14-12-22-19(23-13-14)17-4-1-2-10-21-17/h1-2,4,6-10,12-13H,3,5,11H2,(H,24,27) | Definition date: | 2017-12-07 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | N-[4-(2-oxopyrrolidin-1-yl)phenyl]-2-(pyridin-2-yl)pyrimidine-5-carboxamide |
|
| A9W | Name: | [3-chloranyl-4-(5-methyl-2-oxidanyl-phenyl)phenyl]methylazanium | Formula: | C14 H15 Cl N O | SMILES: | Cc1ccc(O)c(c1)c2ccc(C[NH3+])cc2Cl | InChi: | InChI=1S/C14H14ClNO/c1-9-2-5-14(17)12(6-9)11-4-3-10(8-16)7-13(11)15/h2-7,17H,8,16H2,1H3/p+1 | Definition date: | 2017-08-18 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | [3-chloranyl-4-(5-methyl-2-oxidanyl-phenyl)phenyl]methylazanium |
|
| AFK | Name: | [3-chloranyl-4-(2-methoxy-5-methyl-phenyl)phenyl]methanamine | Formula: | C15 H16 Cl N O | SMILES: | COc1ccc(C)cc1c2ccc(CN)cc2Cl | InChi: | InChI=1S/C15H16ClNO/c1-10-3-6-15(18-2)13(7-10)12-5-4-11(9-17)8-14(12)16/h3-8H,9,17H2,1-2H3 | Definition date: | 2017-08-18 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | [3-chloranyl-4-(2-methoxy-5-methyl-phenyl)phenyl]methanamine |
|
| AFW | Name: | [3-chloranyl-4-[2-methoxy-5-(trifluoromethyl)phenyl]phenyl]methanamine | Formula: | C15 H13 Cl F3 N O | SMILES: | COc1ccc(cc1c2ccc(CN)cc2Cl)C(F)(F)F | InChi: | InChI=1S/C15H13ClF3NO/c1-21-14-5-3-10(15(17,18)19)7-12(14)11-4-2-9(8-20)6-13(11)16/h2-7H,8,20H2,1H3 | Definition date: | 2017-08-18 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | [3-chloranyl-4-[2-methoxy-5-(trifluoromethyl)phenyl]phenyl]methanamine |
|
| BXS | Name: | (2Z)-4-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-4-oxobut-2-enoic acid | Formula: | C12 H10 O6 | SMILES: | c1c(C([C@H]=C(C(O)=O)O)=O)cc2c(c1)OCCO2 | InChi: | InChI=1S/C12H10O6/c13-8(6-9(14)12(15)16)7-1-2-10-11(5-7)18-4-3-17-10/h1-2,5-6,14H,3-4H2,(H,15,16)/b9-6- | Definition date: | 2017-09-01 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | (2Z)-4-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-4-oxobut-2-enoic acid |
|
| C0V | Name: | (2Z)-2-hydroxy-4-(naphthalen-2-yl)-4-oxobut-2-enoic acid | Formula: | C14 H10 O4 | SMILES: | c2cc1ccccc1cc2C([C@H]=C(C(O)=O)O)=O | InChi: | InChI=1S/C14H10O4/c15-12(8-13(16)14(17)18)11-6-5-9-3-1-2-4-10(9)7-11/h1-8,16H,(H,17,18)/b13-8- | Definition date: | 2017-09-07 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | (2Z)-2-hydroxy-4-(naphthalen-2-yl)-4-oxobut-2-enoic acid |
|
| TTW | Name: | 5'-O-[hydroxy{[hydroxy(phosphonoamino)phosphoryl]oxy}phosphoryl]thymidine | Formula: | C10 H18 N3 O13 P3 | SMILES: | O=C1C(=CN(C(N1)=O)C2CC(C(O2)COP(OP(NP(=O)(O)O)(O)=O)(O)=O)O)C | InChi: | InChI=1S/C10H18N3O13P3/c1-5-3-13(10(16)11-9(5)15)8-2-6(14)7(25-8)4-24-29(22,23)26-28(20,21)12-27(17,18)19/h3,6-8,14H,2,4H2,1H3,(H,22,23)(H,11,15,16)(H4,12,17,18,19,20,21)/t6-,7+,8+/m0/s1 | Definition date: | 2017-12-19 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | 5'-O-[(R)-hydroxy{[(R)-hydroxy(phosphonoamino)phosphoryl]oxy}phosphoryl]thymidine |
|
| CQS | Name: | 2-(6-amino-9H-purin-9-yl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide | Formula: | C15 H17 N7 O3 S | SMILES: | C(NCCc1ccc(cc1)S(N)(=O)=O)(Cn3cnc2c3ncnc2N)=O | InChi: | InChI=1S/C15H17N7O3S/c16-14-13-15(20-8-19-14)22(9-21-13)7-12(23)18-6-5-10-1-3-11(4-2-10)26(17,24)25/h1-4,8-9H,5-7H2,(H,18,23)(H2,16,19,20)(H2,17,24,25) | Definition date: | 2017-09-29 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | 2-(6-amino-9H-purin-9-yl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide |
|
| CWQ | Name: | 2-[[(3~{R})-1-(2,3-dihydro-1~{H}-inden-2-yl)piperidin-3-yl]methyl-(8-oxidanylquinolin-2-yl)carbonyl-amino]ethyl-dimethyl-azanium | Formula: | C29 H37 N4 O2 | SMILES: | C[NH+](C)CCN(C[CH]1CCCN(C1)C2Cc3ccccc3C2)C(=O)c4ccc5cccc(O)c5n4 | InChi: | InChI=1S/C29H36N4O2/c1-31(2)15-16-33(29(35)26-13-12-22-10-5-11-27(34)28(22)30-26)20-21-7-6-14-32(19-21)25-17-23-8-3-4-9-24(23)18-25/h3-5,8-13,21,25,34H,6-7,14-20H2,1-2H3/p+1/t21-/m1/s1 | Definition date: | 2017-12-12 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | 2-[[(3~{R})-1-(2,3-dihydro-1~{H}-inden-2-yl)piperidin-3-yl]methyl-(8-oxidanylquinolin-2-yl)carbonyl-amino]ethyl-dimethyl-azanium |
|
| D1Y | Name: | (2Z)-4-(2-chloro-4-hydroxyphenyl)-2-hydroxy-4-oxobut-2-enoic acid | Formula: | C10 H7 Cl O5 | SMILES: | c1cc(O)cc(c1C([C@H]=C(C(O)=O)O)=O)Cl | InChi: | InChI=1S/C10H7ClO5/c11-7-3-5(12)1-2-6(7)8(13)4-9(14)10(15)16/h1-4,12,14H,(H,15,16)/b9-4- | Definition date: | 2017-10-13 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | (2Z)-4-(2-chloro-4-hydroxyphenyl)-2-hydroxy-4-oxobut-2-enoic acid |
|
| D2W | Name: | 4-[2-(dimethylamino)ethoxy]-~{N}-[[(3~{R})-5-(6-methoxypyridin-2-yl)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]benzamide | Formula: | C26 H29 N3 O5 | SMILES: | COc1cccc(n1)c2cccc3OC[CH](CNC(=O)c4ccc(OCCN(C)C)cc4)Oc23 | InChi: | InChI=1S/C26H29N3O5/c1-29(2)14-15-32-19-12-10-18(11-13-19)26(30)27-16-20-17-33-23-8-4-6-21(25(23)34-20)22-7-5-9-24(28-22)31-3/h4-13,20H,14-17H2,1-3H3,(H,27,30)/t20-/m1/s1 | Definition date: | 2017-12-15 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | 4-[2-(dimethylamino)ethoxy]-~{N}-[[(3~{R})-5-(6-methoxypyridin-2-yl)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]benzamide |
|
| E9S | Name: | (2Z)-4-(2-bromo-3-hydroxyphenyl)-2-hydroxy-4-oxobut-2-enoic acid | Formula: | C10 H7 Br O5 | SMILES: | c1ccc(c(c1C([C@H]=C(C(O)=O)O)=O)Br)O | InChi: | InChI=1S/C10H7BrO5/c11-9-5(2-1-3-6(9)12)7(13)4-8(14)10(15)16/h1-4,12,14H,(H,15,16)/b8-4- | Definition date: | 2017-12-14 | Last modified: | 2018-08-31 | Release date: | 2018-09-05 | Identifier: | (2Z)-4-(2-bromo-3-hydroxyphenyl)-2-hydroxy-4-oxobut-2-enoic acid |
|